U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07107841) titled 'Autologous Hair Follicle Secretome for Androgenic Alopecia' on July 31.
Brief Summary: The purpose of this clinical trial is to evaluate the safety and efficacy of the use of an autologous hair follicle derived secretome for androgenous alopecia. The secretome will be injected into the scalp at baseline, and days 30, 90, 180, 270 and 365.
Hair growth will be quantitatively measured for density and thickness. PROs will also be collected from participants.
Study Start Date: Sept. 15
Study Type: INTERVENTIONAL
Condition:
Androgenic Alopecia
Intervention:
OTHER: Autologous Hair Follicle-Derived Secretome
Hair follicles are plucke...